Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023

/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis and inflammation,...

Related Keywords

Seongnam ,Kyonggi Do ,South Korea ,San Francisco ,California ,United States ,South Korean ,Republic Of Korea ,Pavel Printsev ,Hilton San Francisco Union Square ,Biotherapeutics Inc ,Bridge Biotherapeutics Inc ,Biotech Showcase ,Business Development ,Sara Demy ,Pacific Time ,Bridge Biotherapeutics ,Nc ,